Literature DB >> 19948505

Low-level vagosympathetic stimulation: a paradox and potential new modality for the treatment of focal atrial fibrillation.

Shuyan Li1, Benjamin J Scherlag, Lilei Yu, Xia Sheng, Ying Zhang, Reza Ali, Yumei Dong, Muhammad Ghias, Sunny S Po.   

Abstract

BACKGROUND: We used high-frequency stimulation delivered during the refractory period of the atrium and pulmonary veins (PVs) to induce focal firing and atrial fibrillation (AF). This study was designed to demonstrate that bilateral low-level vagosympathetic nerve stimulation (LL-VNS) could suppress high-frequency stimulation-induced focal AF at atrial and PV sites. METHODS AND
RESULTS: In 23 dogs anesthetized with Na-pentobarbital, electrodes in the vagosympathetic trunks allowed LL-VNS at 1 V below that which slowed the sinus rate or atrioventricular conduction. Multielectrode catheters were fixed at the right and left superior and inferior PVs and both atrial appendages. LL-VNS continued for 3 hours. At the end of each hour, the high-frequency stimulation algorithm consisting of a 40-ms train of stimuli (200 Hz; stimulus duration, 0.1 to 1.0 ms) was delivered 2 ms after the atrial pacing stimulus during the refractory period at each PV and atrial appendages site. The lowest voltage of high-frequency stimulation that induced AF was defined as the AF threshold. Five dogs without LL-VNS served as sham controls. Six dogs underwent LL-VNS after transection of bilateral vagosympathetic trunks. LL-VNS induced a progressive increase in AF threshold at all PV and atrial appendages sites, particularly significant (P<0.05) at the right superior PV, right inferior PV, left superior PV, and right atrial appendage. Bilateral vagosympathetic transection did not significantly alter the previous findings, and the 5 sham control dogs did not show changes in AF threshold at any site over a period of 3 hours.
CONCLUSIONS: LL-VNS may prevent episodic AF caused by rapid PV and non-PV firing.

Entities:  

Mesh:

Year:  2009        PMID: 19948505     DOI: 10.1161/CIRCEP.109.868331

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  39 in total

1.  Effects of low-level carotid baroreflex stimulation on atrial electrophysiology.

Authors:  Mingyan Dai; Mingwei Bao; Jiafen Liao; Lilei Yu; Yanhong Tang; He Huang; Xi Wang; Congxin Huang
Journal:  J Interv Card Electrophysiol       Date:  2015-04-15       Impact factor: 1.900

Review 2.  Cardiac autonomic innervation.

Authors:  Hina K Jamali; Fahad Waqar; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2016-11-14       Impact factor: 5.952

3.  Decreased exercise capacity and sleep-disordered breathing in patients with hypertrophic cardiomyopathy.

Authors:  Tomas Konecny; Jeffrey B Geske; Ondrej Ludka; Marek Orban; Peter A Brady; Muaz M Abudiab; Felipe N Albuquerque; Alexander Placek; Tomas Kara; Karine R Sahakyan; Bernard J Gersh; A Jamil Tajik; Thomas G Allison; Steve R Ommen; Virend K Somers
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

Review 4.  Neural mechanisms of atrial arrhythmias.

Authors:  Mark J Shen; Eue-Keun Choi; Alex Y Tan; Shien-Fong Lin; Michael C Fishbein; Lan S Chen; Peng-Sheng Chen
Journal:  Nat Rev Cardiol       Date:  2011-09-27       Impact factor: 32.419

Review 5.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

Review 6.  Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy.

Authors:  Peng-Sheng Chen; Lan S Chen; Michael C Fishbein; Shien-Fong Lin; Stanley Nattel
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 7.  Non-pharmacological, non-ablative approaches for the treatment of atrial fibrillation: experimental evidence and potential clinical implications.

Authors:  Benjamin J Scherlag; Hiroshi Nakagawa; Warren M Jackman; Ralph Lazzara; Sunny S Po
Journal:  J Cardiovasc Transl Res       Date:  2010-11-06       Impact factor: 4.132

Review 8.  Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics.

Authors:  Kalyanam Shivkumar; Olujimi A Ajijola; Inder Anand; J Andrew Armour; Peng-Sheng Chen; Murray Esler; Gaetano M De Ferrari; Michael C Fishbein; Jeffrey J Goldberger; Ronald M Harper; Michael J Joyner; Sahib S Khalsa; Rajesh Kumar; Richard Lane; Aman Mahajan; Sunny Po; Peter J Schwartz; Virend K Somers; Miguel Valderrabano; Marmar Vaseghi; Douglas P Zipes
Journal:  J Physiol       Date:  2016-06-14       Impact factor: 5.182

9.  Effect of the stellate ganglion on atrial fibrillation and atrial electrophysiological properties and its left-right asymmetry in a canine model.

Authors:  Qina Zhou; Jialu Hu; Yujun Guo; Feng Zhang; Xi Yang; Ling Zhang; Xiaoxia Xu; Lingpeng Wang; Hongli Wang; Yuemei Hou
Journal:  Exp Clin Cardiol       Date:  2013

10.  Cardioprotective effects of low-level carotid baroreceptor stimulation against myocardial ischemia-reperfusion injury in canine model.

Authors:  Xia Sheng; Mingxian Chen; Bing Huang; Jia Liu; Liping Zhou; Mingwei Bao; Shuyan Li
Journal:  J Interv Card Electrophysiol       Date:  2016-01-06       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.